Tawam Hospital   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Al Ain United Arab Emirates (1979)

Organization Overview

First Clinical Trial
2006
NCT00336206
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Tawau Hospital

Active Ingredients

Drugs in Phase 4 Trials (6)

cobalamin (1 trial)

folic acid (1 trial)

pyridoxine (1 trial)

riboflavin (1 trial)

tocopherol (1 trial)

vitamin c (1 trial)

Drugs in Phase 3 Trials (1)

favipiravir (1 trial)

Drugs in Phase 2 Trials (2)

nifedipine (procardia) (1 trial)

tractocile (1 trial)

Drugs in Other Trials (3)

alemtuzumab (campath) (1 trial)

arginine (1 trial)

sigma-ureidonorvaline (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 4)

Obstetric Labor, Premature (Phase 2)

Premature Birth (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 12